US FDA takes key actions for bulk drugs used for compounding

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2018年 / 1713卷 / 1期
关键词：
D O I：
10.1007/s40278-018-49838-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [31] US-FDA Approved Drugs in 2020 and 2021: A Review
    Passi, Indu
    Salwan, Sushant
    Kumar, Bhupinder
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2023, 23 (12) : 1273 - 1297
  • [32] US FDA's safety monitoring of drugs with expedited approval
    Furlow, Bryant
    LANCET ONCOLOGY, 2016, 17 (03): : 281 - 281
  • [33] US FDA panel advises banning of two asthma drugs
    Reactions Weekly, 2009, 1238 (1) : 2 - 2
  • [34] Pharmacogenomic characterization of US FDA-approved cytotoxic drugs
    Peters, Eric J.
    Motsinger-Reif, Alison
    Havener, Tammy M.
    Everitt, Lorraine
    Hardison, Nicholas E.
    Watson, Venita G.
    Wagner, Michael
    Richards, Kristy L.
    Province, Mike A.
    McLeod, Howard L.
    PHARMACOGENOMICS, 2011, 12 (10) : 1407 - 1415
  • [35] Clamp down on Rx drugs without US FDA approval
    Reactions Weekly, 2006, 1106 (1) : 3 - 3
  • [36] The Biden Administration Takes Actions to Restructure Migration to the US-Mexico Border
    不详
    AMERICAN JOURNAL OF INTERNATIONAL LAW, 2023, 117 (03) : 528 - 534
  • [37] FDA commissioner notes actions against Internet sige selling prescription drugs
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (09) : 838 - 838
  • [38] Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions
    Pamer, Carol A.
    Hammad, Tarek A.
    Wu, Yu-te
    Kaplan, Sigal
    Rochester, George
    Governale, Laura
    Mosholder, Andrew D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (02) : 158 - 174
  • [39] The US FDA is warning five pharmacies to cease compounding and distributing standardised versions of topical anaesthetic creams
    Reactions Weekly, 2006, 1132 (1) : 3 - 3
  • [40] Characteristics Of Key Patents Covering Recent FDA-Approved Drugs
    Van de Wiele, Victor L.
    Torrance, Andrew W.
    Kesselheim, Aaron S.
    HEALTH AFFAIRS, 2022, 41 (08) : 1117 - 1124
12345